CA3279710A1 - Formes cristallines de 6-(3-((5-chloro-2-méthoxypyridine)-3-sulfonamido)-2,6-difluorophényl)-n-méthylimidazo [l,5-ajpyrazine-l-carboxamide et leurs procédés d'utilisation - Google Patents

Formes cristallines de 6-(3-((5-chloro-2-méthoxypyridine)-3-sulfonamido)-2,6-difluorophényl)-n-méthylimidazo [l,5-ajpyrazine-l-carboxamide et leurs procédés d'utilisation

Info

Publication number
CA3279710A1
CA3279710A1 CA3279710A CA3279710A CA3279710A1 CA 3279710 A1 CA3279710 A1 CA 3279710A1 CA 3279710 A CA3279710 A CA 3279710A CA 3279710 A CA3279710 A CA 3279710A CA 3279710 A1 CA3279710 A1 CA 3279710A1
Authority
CA
Canada
Prior art keywords
methylimidazo
methoxypyridine
sulfonamido
difluorophenyl
pyrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3279710A
Other languages
English (en)
Inventor
Xiawei JIANG
Pengyuan Chen
Original Assignee
Hibercell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hibercell Inc filed Critical Hibercell Inc
Publication of CA3279710A1 publication Critical patent/CA3279710A1/fr
Pending legal-status Critical Current

Links

CA3279710A 2023-01-20 2024-01-19 Formes cristallines de 6-(3-((5-chloro-2-méthoxypyridine)-3-sulfonamido)-2,6-difluorophényl)-n-méthylimidazo [l,5-ajpyrazine-l-carboxamide et leurs procédés d'utilisation Pending CA3279710A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNPCT/CN2023/073337 2023-01-20

Publications (1)

Publication Number Publication Date
CA3279710A1 true CA3279710A1 (fr) 2024-07-25

Family

ID=

Similar Documents

Publication Publication Date Title
CA3296895A1 (en) Crystalline forms of (s)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making
CA3267196A1 (fr) Dérivés de 4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-naphthalene-pyrido[4,3-d]pyrimidine en tant qu'inhibuteurs de l'oncoprotéine mutante kras(g12d) pour le traitement du cancer inhibiteurs de kras (g12d)
CA3261000A1 (fr) Composés pyrido[4,3-d]pyrimidines
PT1155015E (pt) Processo para a preparação de (e)-(6-¬2-¬4-(4-fluorofenil)-6- isopropil-2-¬metil(metilsulfonil)amino pirimidin-5-il vinil(4r,6s)-2,2-dimetil¬1,3 dioxan-4-il)acetato de terc-butilo
WO2009108838A8 (fr) Dérivés hétérocycliques bicycliques pontés ou hétérocycliques bicycliques spiro de pyrazolo[1,5-a]pyrimidines, leurs procédés de préparation et leurs utilisations
EE05222B1 (et) Triasolo(4,5-d)primidiinihendi kristalne ja amorfne vorm, meetod selle valmistamiseks ning kasutamine
WO2003062236A8 (fr) 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
WO2007013896A3 (fr) Composes modulant l'activite de c-kit et c-fms et utilisations
NZ590922A (en) Piperidine derivatives as jak3 inhibitors
WO2004106340A3 (fr) Derives substitues en 4 de pyrazolo[3,4-d]pyrimidine et pyrrolo[2,3-d]pyrimidine et utilisations associees
EP3856743A4 (fr) Composés imidazo [1, 2-a] pyridine et [1, 2, 4] triazolo [1, 5-a] pyridine substitués en tant qu'inhibiteurs de kinase ret
AU2023406484A1 (en) Crystalline forms of n,n-dimethyltryptamine and methods of using the same
CA3279710A1 (fr) Formes cristallines de 6-(3-((5-chloro-2-méthoxypyridine)-3-sulfonamido)-2,6-difluorophényl)-n-méthylimidazo [l,5-ajpyrazine-l-carboxamide et leurs procédés d'utilisation
WO2006033795A3 (fr) Methode d'utilisation de pyrazolo [1,5-a] pyrimidines substituees
RS67793B1 (sr) Kristalni oblici 5-(3,4-difluorbenzil)-8-((1r,4r)-4-metilcikloheksil)-6,9-diokso-2,5,8-triazapiro[3.5]nonan-2-karbaldehida
WO2006069193A3 (fr) Compose d'imidazo[4,5-c]pyridine et traitement antiviral dans lequel est utilise ledit compose
MY201313A (en) Improved method for the manufacture of 3-[(1s)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof
CA3306594A1 (fr) Sel de 2-(4-(2-(7, 8-diméthyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl)pipéridin-1-yl)acétamide et ses formes cristallines
CA3277023A1 (fr) Formes solides de 5-cyclopropyl-2-[2- (3,6-difluoro-pyridin-2-ylamino)-pyridin-4-yl]-pyrido [3,4-d] pyrimidin-4-yl}- ((s) -3,3-diméthyl-pipéridin-4-yl)-amine
HK40103339A (en) Pyrazolo[1,5-a]pyrimidine compound for the treatment of dermal disorders
HK40120959A (en) Pyrazolo[1,5-a]pyridine derivatives for treating trpm3- mediated disorders
CA3290161A1 (fr) Dérivés de pyrido[4,3-d]pyrimidine utilisés comme inhibiteurs de la protéine mutante kras g12c pour le traitement du cancer
IL321456A (en) Solid forms of {5-cyclopropyl-2-[2-(3,6-difluoro¬pyridin-2-ylamino)-pyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-yl }-( (s)-3,3-dimethyl-piperidin-4-yl)-amine
HK40090671A (en) Pyrazolo[1,5-a]pyrimidine derivatives having multimodal activity against pain
HK40109573A (en) Pyrido[4,3-d]pyrimidine compounds capable of inhibiting kras mutant proteins